Submission & CMC
AI-Enabled CMC & Regulatory Modernization
Modernize CMC around the evidence and data model—not around the AI tool.
XGene helps life-sciences teams identify where structured content and AI-assisted workflows can improve CMC traceability, reuse, review and decision support while preserving accountable human scientific and regulatory judgment.
Starting point: AI-Enabled CMC Readiness & Structured Content Assessment
Decision lens
What this service is designed to connect.
Connect structured content, provenance, traceability, fit-for-use governance, and accountable human review before automating a workflow.
- 01MapInformation flow
- 02StructureContent & data
- 03GovernHuman review
- 04PilotMeasure & verify
Modernize CMC around the evidence and data model — not around the AI tool.
XGene helps life-sciences teams identify where structured content and AI-assisted workflows can improve CMC traceability, reuse, review and decision support while preserving accountable human scientific and regulatory judgment.
When this service is the right fit
- Teams are experimenting with generative AI before deciding which CMC decisions, data and documents are appropriate for automation.
- Legacy Module 3 content is duplicated across templates, submissions, regions and lifecycle changes.
- Source data, specifications, methods, batch information and narrative content are not connected in reusable structures.
- AI outputs cannot be trusted because source provenance, review ownership and change control are weak.
- The organization wants to prepare for structured PQ/CMC concepts or EU IDMP/SPOR data needs without overstating current regulatory mandates.
- Technology, regulatory and quality teams lack a common governance model for AI-assisted CMC work.
What XGene does
- Map the current CMC information lifecycle from source systems and evidence through authoring, review, approval and reuse.
- Identify high-value/low-risk structured-content and AI use cases before selecting tools.
- Define reusable content components, metadata, data relationships and provenance requirements.
- Establish human-review, validation, access, change-control and audit-trail expectations appropriate to the intended use.
- Assess readiness against relevant structured-data directions such as FDA PQ/CMC and EU IDMP/SPOR while distinguishing current obligations from future-facing architecture.
- Design pilot workflows with measurable quality, review-efficiency and traceability objectives.
What the engagement produces
- CMC information-flow and pain-point map
- AI/automation use-case prioritization matrix
- Structured-content and metadata architecture
- Source-provenance and human-review governance model
- PQ/CMC and IDMP/SPOR readiness assessment
- Pilot roadmap with acceptance criteria and measurement plan
Productized starting point — AI-Enabled CMC Readiness & Structured Content Assessment
The AI-Enabled CMC Readiness & Structured Content Assessment is the recommended first engagement when the organization needs an independent, evidence-based view before committing to a larger remediation, authoring, transformation or execution program. It is designed to identify the decision-critical gaps, clarify scope and produce a prioritized path forward without forcing the client into an oversized engagement at the outset.
How XGene works
1. Define the business/regulatory decision the technology should improve.
2. Map the evidence, content and data dependencies.
3. Diagnose where structure or automation reduces friction without weakening control.
4. Design the governed operating architecture, not just prompts or tools.
5. Stress-test provenance, human review, change control and failure handling before scale-up.
Senior practitioners aligned to this work
- Khaled Aamer, PhD
- a senior XGene quality-systems and operational-excellence practitioner
Experience brought to XGene
The following examples demonstrate relevant practitioner experience. They are not presented as XGene-delivered client outcomes unless explicitly stated otherwise.
- More than 200 legacy CMC templates converted into structured, reusable authoring components with FHIR-HL7 and AI-enabled authoring approaches in prior-role experience (Khaled Aamer).
- Current team experience includes AI/data-driven decision support in quality and CMC operational workflows; public outcome claims require individual-source attribution.
Engagement boundary
XGene is positioning this as consulting and modernization support, not as a claim that XGene currently operates a proprietary validated AI software platform. AI is an enabling layer; accountable CMC judgment remains human-owned.
Move from scope to action
Bring the decision, evidence, and timing.
Use non-confidential information. XGene can help determine whether a project discussion or focused assessment is the right next step.
